Peer-reviewed veterinary case report
Canine flu vaccine protects dogs from avian-origin H3N2 virus
By Lee, Chulseung et al.·Published in Veterinary microbiology·2010·Chungang University School of Medicine, South Korea·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Protective efficacy and immunogenicity of an inactivated avian-origin H3N2 canine influenza vaccine in dogs challenged with the virulent virus.
- Species:
- dog
Plain-English summary
A group of beagle puppies received two doses of an inactivated vaccine to protect against the H3N2 canine influenza virus, which can spread between dogs. After vaccination, the puppies showed a significant increase in protective antibodies. When exposed to the virus, the vaccinated puppies did not show any symptoms and had milder lung issues compared to unvaccinated puppies, who experienced more severe illness. This study suggests that the vaccine is effective in protecting dogs from this strain of influenza.
People also search for: dog flu vaccine effectiveness · H3N2 influenza symptoms in dogs · beagle puppy vaccination schedule
Abstract
Transmission of avian-origin influenza A virus (H3N2) to dogs had been reported and since then the H3N2 virus infection across South Korea has been occurred repeatedly in the country's animal clinics and kennels. Dog-to-dog transmission of the virus had also been experimentally demonstrated by direct contact. In this study, immunogenicity and protective efficacy against challenge exposure of the formalin-inactivated H3N2 influenza virus vaccine with a synthetic polymer adjuvant was investigated in dogs. The beagle puppies received two inactivated vaccine injections intramuscularly 2 weeks apart. Serological investigation by a hemagglutination inhibition (HI) test and an ELISA assay indicated that a significant increase in antibody titer was displayed 2 weeks after the second vaccination. Clinical signs, virus shedding and histopathological lesions in the lungs were exhibited in unvaccinated beagle puppies directly challenged through an intranasal route with the virus 2 weeks after the second vaccination. However, the vaccinated animals did not show any clinical signs and showed milder pathological lung lesions and shorter shedding duration with lower loads than controls'. These results indicated that the synthetic polymer-adjuvant avian-origin canine influenza virus (CIV) vaccine had produced antibody response and protection from avian-origin CIV challenge in dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/20034748/